A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Part of paid clinical trials in Fountain Valley, California.
- Sponsor
- Bausch Health Americas, Inc.
- Study ID
- NCT03987763
- Phase
- PHASE4
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- IDP-122 Lotion — DRUGTopical
Study Details
This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically applied IDP-122 lotion in pediatric participants with moderate to severe plaque psoriasis.
Key Dates
- Start date
- Oct 22, 2019
- Status verified
- Aug 2025
- Primary completion
- May 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: IDP-122 LotionTwo cohorts of pediatric participants (1 cohort of participants age 12 to 16 years 11 months and 1 cohort of participants age 6 to 11 years 11 months) will apply IDP-122 Lotion to Investigator identified lesions affecting a minimum of 10% body surface area (BSA) once daily for 8 weeks.
Primary Outcome Measure
Pharmacokinetics: Maximum Observed Drug (Halobetasol Propionate) Concentration in Plasma (Cmax) of IDP-122 Lotion Analytes [ Time Frame: 0 (predose), 1, 2, 4, 8, 12, and 24 hours postdose ]
Central Contacts
- Alison Magnotti-Nagel9085418664
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bausch Site 11 | Fountain Valley | California | 92708 | - |
| Bausch Site 2 | Thousand Oaks | California | 91320 | - |
| Bausch Site 07 | Doral | Florida | 33166 | - |
| Bausch Site 06 | Miami | Florida | 33155 | - |
| Bausch Site 3 | Miami | Florida | 33125 | - |
| Bausch Site 05 | Spartanburg | South Carolina | 29303 | - |
| Bausch Site 1 | Spokane | Washington | 99216 | - |
Find similar trials in Fountain Valley, CA
By condition
By specialty
Related Studies
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Study of SFA002 in Patients with Mild to Moderate Psoriasis PlaquesPHASE1 · Recruiting · SFA Therapeutics · Pompano Beach, Florida
- Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced DietRecruiting · University of California, Davis · Sacramento, California